预测患有第三期非小细胞肺癌的患者的整体存活率,这些患者正在接受外科手术期间的化疗或放射治疗
Ying Kong1, Liang Hong, Xiaocheng Xu
1Department of Oncology, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.
Medicine
|November 5, 2025
概括
一种新的诺莫图谱预测了接受外科手术期间化疗或放射治疗的第三期非小细胞肺癌 (NSCLC) 患者的生存率. 该工具有助于个性化治疗规划和评估手术和治疗后患者的结果.
科学领域:
- 在瘤学瘤学.
- 医学统计 医学统计
背景情况:
- 辅助化学辐射疗法改善了局部晚期非小细胞肺癌 (NSCLC) 手术后的存活率,但新辅助方法仍在争论中.
- 准确的预后工具对于在接受外科手术期间化疗或放射治疗的第三阶段NSCLC患者的治疗量身定制至关重要.
研究的目的:
- 开发和验证一种预后性诺图谱,用于预测在接受外科手术期间化疗或放射治疗的第三阶段NSCLC患者的整体存活率 (OS).
- 评估名图的准确性,预测性能和临床实用性,以进行个性化的生存预测.
主要方法:
- 多变量考克斯回归分析从8148名第三阶段NSCLC患者中发现了显著的预后变量.
- 使用这些变量构建了一个名图,以预测12,36和60个月后的OS.
- 协同指数,校准曲线和决策曲线分析 (DCA) 用于验证和临床实用性评估.
主要成果:
- 对于名ogram,有9个显著变量被确定.
- 在训练和验证队列中,名图显示出良好的预测准确性,曲线下的面积 (AUC) 在训练和验证队列中的时间点范围从0.6到0.626.
- 校准图片证实了预测和观察到的生存率之间的一致性,DCA支持了临床适用性.
结论:
- 一个经过验证的预后诺图可以为接受外科手术期间化疗或放射治疗的第三阶段NSCLC患者提供个性化的生存预测.
- 诺米图帮助临床医生评估治疗效益,并为患者管理提供了宝贵的见解.
- 进一步的研究可能会完善NSCLC的预后模型,增强个性化治疗策略.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
482
相关概念视频
01:21Cancer Survival Analysis
639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639
01:20Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548